Heron Therapeuti
Price & Volume
Stats
See more52W Range | $0.73-$2.61 |
Market Cap | $160.8M |
Shares Short | 39M |
Financials
See moreRevenue (12 Mos) | $154.9M |
Revenue Growth (YoY) | -0.5% |
Gross Profit (12 Mos) | $112.5M |
Diluted EPS | -$0.12 |
News
See moreYahoo Finance • 2 months ago
Heron Therapeutics outlines $173M–$183M 2026 sales targets amid acute care momentum and expanded commercial investment
Yahoo Finance • 4 months ago
Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)
Yahoo Finance • 6 months ago
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
Yahoo Finance • 6 months ago
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
About
CEO | Mr. Craig Alexander Collard |
CFO | Ms. Ira Duarte |
Address | 100 Regency Forest Drive, Cary, NC, United States, 27518 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 128 |
